Medicare

  • Your Selections:

Refine Results

date

Topics

Content Type

Tags

How Could the Price of Remdesivir Impact Medicare Spending for COVID-19 Patients?

This brief discusses how drugs provided in inpatient hospital settings are covered and reimbursed for beneficiaries in traditional Medicare under current law. This is relevant for Medicare spending on COVID-19 patients who receive Gilead’s new antiviral drug remdesivir. We discuss the possible scenarios for hospitals and the Medicare program depending on different pricing levels for the drug.

Insulin Costs and Coverage in Medicare Part D

In light of heightened attention to insulin and the Trump Administration’s new Part D model to address out-of-pocket costs for insulin for Medicare beneficiaries, we analyzed out-of-pocket spending on insulin by beneficiaries enrolled in Part D drug plans, variation in Part D plan formulary coverage and tier placement of insulin products, and trends in prices for insulin.

COVID-19 and Workers at Risk: Examining the Long-Term Care Workforce

The highly transmissible nature of the coronavirus combined with the congregate nature of long-term care facility settings and the close and personal contact that many long-term care workers have with patients puts them at elevated risk of infection. This analysis focuses on the characteristics of the 4.5 million people who work in long-term care settings, based on the 2018 American Community Survey.

A Dozen Facts About Medicare Advantage in 2020

Medicare Advantage enrollment has grown rapidly over the past decade, and Medicare Advantage plans have taken on a larger role in the Medicare program. More than 24 million Medicare beneficiaries (36%) are enrolled in Medicare Advantage plans in 2020. This data analysis provides updated information about Medicare Advantage enrollment trends, premiums, and out-of-pocket limits. It also includes analyses of Medicare Advantage plans’ extra benefits and prior authorization requirements. The analysis also highlights changes pertaining to Medicare Advantage coverage that have occurred in 2020 in response to the COVID-19 crisis.